GOLT1A and breast cancer: These results show that miR-378a-3p and its target GOLT1A can provide new insights into the signaling pathways associated with tamoxifen resistance in breast cancer and could be applied to the development of alternative diagnostic and therapeutic options for advanced breast cancer.